awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27853062-25D88F5B-FAF6-4486-99EA-B0AE4B141818
Q27853062-25D88F5B-FAF6-4486-99EA-B0AE4B141818
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853062-25D88F5B-FAF6-4486-99EA-B0AE4B141818
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
P2860
Q27853062-25D88F5B-FAF6-4486-99EA-B0AE4B141818
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853062-25D88F5B-FAF6-4486-99EA-B0AE4B141818
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ccc1696c24bb645cec5eb054e238b6c40a10ea7c
P2860
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.